Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Rix

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Science Signaling|December 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Blood|June 18, 2011
KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinibKaroline V Gleixner, Matthias Mayerhofer, Sabine Cerny-Reiterer, et al.
Cell Chemical Biology|July 30, 2021
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitorsVinayak Palve, Claire E Knezevic, Daniel S Bejan, et al.
Science Signaling|February 14, 2019
An immunoproteomic approach to characterize the CAR interactome and signalosomeMaria C Ramello, Ismahène Benzaïd, Brent M Kuenzi, et al.
Blood|January 9, 2008
The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophilsMichael Kneidinger, Uwe Schmidt, Uwe Rix, et al.
Molecular Systems Biology|February 21, 2015
Targeting a cell state common to triple-negative breast cancersMarkus K Muellner, Barbara Mair, Yasir Ibrahim, et al.
Molecular Systems Biology|November 6, 2013
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanismsJiannong Li, Keiryn Bennett, Alexey Stukalov, et al.
Science Signaling|August 16, 2022
IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cellsLily L Remsing Rix, Natalia J Sumi, Qianqian Hu, et al.
Cancer Research|April 22, 2017
EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion KinasesAria Vaishnavi, Laura Schubert, Uwe Rix, et al.
Cancer Immunology Research|March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityManali S Phadke, Zhihua Chen, Jiannong Li, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Science Signaling|December 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Blood|June 18, 2011
KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinibKaroline V Gleixner, Matthias Mayerhofer, Sabine Cerny-Reiterer, et al.
Cell Chemical Biology|July 30, 2021
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitorsVinayak Palve, Claire E Knezevic, Daniel S Bejan, et al.
Science Signaling|February 14, 2019
An immunoproteomic approach to characterize the CAR interactome and signalosomeMaria C Ramello, Ismahène Benzaïd, Brent M Kuenzi, et al.
Blood|January 9, 2008
The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophilsMichael Kneidinger, Uwe Schmidt, Uwe Rix, et al.
Molecular Systems Biology|February 21, 2015
Targeting a cell state common to triple-negative breast cancersMarkus K Muellner, Barbara Mair, Yasir Ibrahim, et al.
Molecular Systems Biology|November 6, 2013
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanismsJiannong Li, Keiryn Bennett, Alexey Stukalov, et al.
Science Signaling|August 16, 2022
IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cellsLily L Remsing Rix, Natalia J Sumi, Qianqian Hu, et al.
Cancer Research|April 22, 2017
EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion KinasesAria Vaishnavi, Laura Schubert, Uwe Rix, et al.
Cancer Immunology Research|March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityManali S Phadke, Zhihua Chen, Jiannong Li, et al.
Pageof 9